The 35 references in paper B. Lukichev G., V. Strelko V., A. Mosikyan A., V. Trikhleb A., Б. Лукичёв Г., В. Стрелко В., А. Мосикян А., В. Трихлеб А. (2014) “СОВРЕМЕННОЕ СОСТОЯНИЕ ВОПРОСА ОБ ИСПОЛЬЗОВАНИИ ЭНТЕРОСОРБЦИИ ПРИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК // THE CURRENT STATE OF THE PROBLEM ABOUT THE USE OF ENTEROSORPTION IN CKD” / spz:neicon:nefr:y:2014:i:6:p:43-50

1
Шостка Г.Д. Рябов С.И. Лукичев Б.Г. и др. Пероральные сорбенты в терапии хронической почечной недостаточности. Тер.архив – 1984 - No7 – с.58-63 [Shostka G.D. Riabov S.I. Lukichev B.G. i dr. Peroral`ny`e sorbenty` v terapii khronicheskoi` pochechnoi` nedostatochnosti. Ter.arhiv – 1984 - No7 – s.58-63]
(check this in PDF content)
2
Рябов С.И., Цюра В.И., Лукичев Б.Г. и др. Энтеросорбция при экспериментальной острой почечной недостаточности. Урология и нефрология. – 1990 - No6. – с.44-49 [Riabov S.I., TCiura V.I., Lukichev B.G. i dr. E`nterosorbtciia pri e`ksperimental`noi` ostroi` pochechnoi` nedostatochnosti. Urologiia i nefrologiia. – 1990 - No6. – s.44-49]
(check this in PDF content)
3
Лукичев Б.Г., Шостка Г.Д., Стрелко В.В. и др. 10-летний опыт применения энтеросорбентов для лечения хронической почечной недостаточности. Тер.архив – 1992 - No8 – с.52-57 [Lukichev B.G., Shostka G.D., Strelko V.V. i dr. 10-letneyi` opy`t primeneniia e`nterosorbentov dlia lecheniia khronicheskoi` pochechnoi` nedostatochnosti. Ter.arhiv – 1992 - No8 – s.52-57]
(check this in PDF content)
4
Hatakeyama S(1), Yamamoto H, Okamoto A, et al. Effect of an Oral Adsorbent, «AST-120», on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease. Int J Nephrol. 2012;2012:376128.
(check this in PDF content)
5
Sanaka T(1), Akizawa T, Koide K, Koshikawa S. Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis. Ther Apher Dial. 2003 Apr;7(2):269-78.
(check this in PDF content)
6
Лукичев Б.Г., Панина И.Ю. Прогнозирование эффективности энтеросорбции при хронической почечной недостаточности. Нефрология – 2005 – Т.9 No 1 – с. 8994 [Lukichev B.G., Panina I.Iu. Prognozirovanie e`ffektivnosti e`nterosorbtcii pri khronicheskoi` pochechnoi` nedostatochnosti. Nefrologiia – 2005 – T.9 No 1 – s. 89-94]
(check this in PDF content)
7
Niwa T(1), Yazawa T, Ise M, et al. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxylsulfate in serum of experimental uremic rats. Nephron. 1991;57(1):84-8
(check this in PDF content)
8
Niwa T(1), Miyazaki T, Hashimoto N, et al. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats. Am J Nephrol. 1992;12(4):201-6
(check this in PDF content)
9
Niwa T(1), Miyazaki T, Tsukushi S, et al. Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis. Nephron. 1996;74(1):72-8.
(check this in PDF content)
10
Kobayashi N(1), Maeda A, Horikoshi S, et al. Effects of oral adsorbent «AST-120» («Kremezin») on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats. Nephron. 2002 Jul;91(3):480-5.
(check this in PDF content)
11
Sanaka T(1), Sugino N, Teraoka S, Ota K. Therapeutic effects of oral sorbent in undialyzed uremia. Am J Kidney Dis. 1988 Aug 12(2):97-103.
(check this in PDF content)
12
Koide K(1), Sano M, Takeda F, et al. A study of oral adsorbent in chronic renal failure. Biomater Artif Cells Immobilization Biotechnol. 1991;19(1):147-66.
(check this in PDF content)
13
Niwa T(1), Nomura T, Sugiyama S, et al. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. 1. Kidney Int Suppl. 1997 Nov;62:S23-8.
(check this in PDF content)
14
Takahashi N(1), Kawaguchi T, Suzuki T. Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: two-year study. Int J Urol. 2005 Jan;12(1):7-11.
(check this in PDF content)
15
Sanaka T(1), Akizawa T, Koide K, Koshikawa S. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy. Ther Apher Dial. 2004 Jun;8(3):232-40.
(check this in PDF content)
16
Shoji T(1), Wada A, Inoue K, et al. Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon «AST-120» in chronic kidney disease patients with moderate decrease in renal function. Nephron Clin Pract. 2007;105(3):c99-107. Epub 2006 Dec 15.
(check this in PDF content)
17
Schulman G(1), Agarwal R, Acharya M, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of «AST-120» («Kremezin») in patients with moderate to severe CKD. Am J Kidney Dis. 2006 Apr;47(4):565-77.
(check this in PDF content)
18
Ueda H(1), Shibahara N, Takagi S, et al. «AST-120», an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. Ther Apher Dial. 2007 Jun;11(3):189-95.
(check this in PDF content)
19
Ueda H(1), Shibahara N, Takagi S, et al. «AST-120» treatment in pre-dialysis period affects the prognosis in patients on hemodialysis. Ren Fail. 2008;30(9):856-60.
(check this in PDF content)
20
Aoyama I(1), Miyazaki T, Niwa T. Preventive effects of an oral sorbent on nephropathy in rats. Miner Electrolyte Metab. 1999 Jul-Dec;25(4-6):365-72.
(check this in PDF content)
21
Aoyama I(1), Enomoto A, Niwa T. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S8-14.
(check this in PDF content)
22
Miyazaki T(1), Aoyama I, Ise M, et al. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant. 2000 Nov;15(11):1773-81
(check this in PDF content)
23
Okada K(1), Matsumoto K, Takahashi S. Oral adsorbent prevents reduction of anionic sites of the glomerular basement membrane in diabetic nephropathy. Nephron Exp Nephrol. 2005;99(2):e56-62.
(check this in PDF content)
24
Okada K(1), Matsumoto K, Takahashi S. Uremic toxins adsorbed by «AST-120» promote tubular hypertrophy and interstitial fibrosis in nephrectomized rats. Kidney Blood Press Res. 2005;28(1):8-13.
(check this in PDF content)
25
Nakagawa N(1), Hasebe N, Sumitomo K, Fujino А. et al. An oral adsorbent, «AST-120», suppresses oxidative stress in uremic rats. Am J Nephrol. 2006;26(5):455-61.
(check this in PDF content)
26
Fujii H(1), Nishijima F, Goto S, et al. Oral charcoal adsorbent («AST-120») prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol Dial Transplant. 2009 Jul;24(7):2089-95.
(check this in PDF content)
27
Shimoishi K(1), Anraku M, Kitamura K, et al. An oral adsorbent, «AST-120» protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Pharm Res. 2007 Jul;24(7):1283-9.
(check this in PDF content)
28
Taki K(1), Niwa T. Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease. J Ren Nutr. 2007 Jan;17(1):48-52.
(check this in PDF content)
29
Niwa T(1), Tsukushi S, Ise M, et al. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab. 1997;23(3-6):179-84.
(check this in PDF content)
30
Owada A(1), Nakao M, Koike J, et al. Effects of oral adsorbent «AST-120» on the progression of chronic renal failure: a randomized controlled study. Kidney Int Suppl. 1997 Dec;63:S188-90.
(check this in PDF content)
31
Imai E(1), Takenaka M, Isaka Y, et al. Carbonic adsorbent «AST-120» retards progression of renal failure by additive effect with ACEI and protein restriction diet. Clin Exp Nephrol. 2003 Jun;7(2):113-9.
(check this in PDF content)
32
Okada K(1), Okawa E, Shibahara H, et al. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure. Kidney Blood Press Res. 2004;27(4):218-25.
(check this in PDF content)
33
Sanaka T(1), Fujimoto K, Niwayama J, et al. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S35-7.
(check this in PDF content)
34
Yorioka N(1), Kiribayashi K, Naito T, et al. An oral adsorbent, «AST-120», combined with a low-protein diet and RAS blocker, for chronic kidney disease. J Nephrol. 2008 Mar-Apr;21(2):213-20.
(check this in PDF content)
35
Kang HY(1), Cho W, Lee S, et al. Estimating the cost savings due to the effect of «Kremezin» in delaying the initiation of dialysis treatments among patients with chronic renal failure. J Prev Med Public Health. 2006 Mar;39(2):149-58. Авторы заявляют об отсутствии конфликта
(check this in PDF content)